2025 HCPCS Code Q5134
Injection, natalizumab-sztn (tyruko), biosimilar, 1 mg
| Short Description | Inj, tyruko, 1 mg |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Action Effective Date | April 01, 2024 |
| HCPCS Code Added Date | April 01, 2024 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- Q0519 - Supply fee hiv prep inj 30
- Q0520 - Supply fee hiv prep inj 60
- Q0521 - Supply fee hiv prep fda appr
- Q1004 - Ntiol category 4
- Q1005 - Ntiol category 5
- Q2004 - Bladder calculi irrig sol
- Q2009 - Fosphenytoin inj pe
- Q2017 - Teniposide, 50 mg
- Q2026 - Radiesse injection
- Q2028 - Inj, sculptra, 0.5mg
- Q2034 - Agriflu vaccine
- Q2035 - Afluria vacc, 3 yrs & >, im
- Q2036 - Flulaval vacc, 3 yrs & >, im
- Q2037 - Fluvirin vacc, 3 yrs & >, im
- Q2038 - Fluzone vacc, 3 yrs & >, im
- Q2039 - Influenza virus vaccine, nos
- Q2040 - Tisagenlecleucel car-pos t
- Q2041 - Axicabtagene ciloleucel car+
- Q2042 - Tisagenlecleucel car-pos t
- Q2043 - Sipuleucel-t auto cd54+